MedPath

Thomas Gleason

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Detection of Hypoxia in Human Thoracic Aorta Using Pimonidazole Hydrochloride

Phase 1
Suspended
Conditions
Aortic Aneurysm, Thoracic
Interventions
First Posted Date
2018-01-25
Last Posted Date
2025-04-02
Lead Sponsor
Thomas Gleason
Target Recruit Count
40
Registration Number
NCT03410420
Locations
🇺🇸

University of Pittsburgh, Pittsburgh, Pennsylvania, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.